Search Now

Recommendations

Wednesday, November 22, 2006

Prabhudas Lilladher: Positive on RPG Life Sciences


According to the brokerage house, the company expects to grow its top line by 20%, while the bottom line is expected to grow by 25% in the next couple of years and also aiming at a turnover of Rs 4.5bn by 2010.

They estimate EPS of Rs 14 and Rs 17.8 for FY07 and FY08 respectively. The stock trades at 8.1x FY07E and 6.3x FY08E earnings and remain positive on the prospects for the stock.

Download here